Indivior PLC revenue for the last year amounted to 1.19 B USD, the most of which — 1.19 B USD — came from its highest performing source at the moment, Buprenorphine-based Prescription Drugs, the year earlier bringing 1.09 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Indivior PLC 1.01 B USD, and the year before that — 912.00 M USD.